Canton Strategic Holdings, Inc. Announces Sale of Gravitas Life Sciences, LLC
Canton Strategic Holdings Inc CNTN
$1.93
▲ +4.32%
(+$0.08)
🗓️ Earnings Next Week
Open
$1.86
Prev Close
$1.85
Day Range
$1.75 – $1.95
52W Range
$1.08 – $9.08
Market Cap
$148.85M
Beta
1.51
EPS (TTM)
$-2.13
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2022-01-12 |
| Shares Out. | 77,120,000 |
| Website | cantonstrategic.com ↗ |
| Phone | 13026457400 |
| Employees | 12 |
| Net Income | -$47.3M |
| Total Assets | $584.7M |
| Total Liabilities | $114.9M |
| Equity | $469.8M |
About Canton Strategic Holdings Inc
Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.
Canton Strategic Holdings Inc is a publicly traded company under the ticker symbol CNTN on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2025-12-01)